ESC 365 - Doctor Kateryna Sopova

Speaker illustration

Doctor Kateryna Sopova

University Medical Centre of Mannheim, Mannheim (Germany)

Member of:

Presentations Articles

Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease

Event: Frontiers in CardioVascular Biomedicine 2024

Topic: Biomarkers

Session: Targets and markers of cardiometabolic disease

Circulating amyloid-beta 1-40 levels associate with cardiac remodelling and myocardial recovery in advanced heart failure

Event: ESC Congress 2023

Topic: Biomarkers

Session: Novel biomarkers in heart failure

Interferon-gamma inducible protein IP-10 and left ventricular remodelling post-acute myocardial infarction: a longitudinal cardiovascular magnetic resonance imaging substudy of CAPRI clinical trial

Event: ESC Congress 2020

Topic: Inflammation and Immunity

Session: Coronary Artery Disease (Chronic) ePosters

Prognostic and reclassification value of serum cathepsin S over the GRACE risk score in patients with non-ST-segment elevation acute coronary syndrome

Event: ESC Congress 2020

Topic: Biomarkers

Session: Risk Factors and Prevention ePosters

Circulating serum extracellular matrix degradation enzyme cathepsin S predicts mortality and improves risk stratification over the GRACE score in patients with non-ST elevation acute coronary syndrom

Event: ESC Congress 2019

Topic: Biomarkers

Session: Non-troponin biomarkers in acute coronary syndromes

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources